Generic and brand-name drugs. Are different criteria sufficiently taken into account before granting market authorisation?

ML Laroche, L Merle - Acta Clinica Belgica, 2006 - Taylor & Francis
Generic or non-proprietary drugs play an increasing part in the French pharmaceutical
market. These copies of the original brand name medicines are available once drug patents …
被引用次数：8 相关文章

[引用][C] Generic and brand-name drugs. Are different criteria sufficiently taken into account before granting market authorisation?

ML Laroche, L Merle - Acta clinica Belgica, 2006 - pubmed.ncbi.nlm.nih.gov

[引用][C] Generic and brand-name drugs. Are different criteria sufficiently taken into account before granting market authorisation?

ML LAROCHE, L MERLE - Acta Clinica Belgica …, 2006 - pascal-francis.inist.fr
Generic and brand-name drugs. Are different criteria sufficiently taken into account before
granting market authorisation? CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[引用][C] Generic and brand-name drugs. Are different criteria sufficiently taken into account before granting market authorisation?

ML Laroche, L Merle - Acta Clinica Belgica, 2006 - europepmc.org
Generic and brand-name drugs. Are different criteria sufficiently taken into account before
granting market authorisation? - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

[引用][C] Generic and brand-name drugs. Are different criteria sufficiently taken into account before granting market authorisation?

ML LAROCHE, L MERLE - Acta clinica belgica, Supplementum, 2006 - Acta Clinica Belgica